Torrent Pharma Consolidated December 2020 Net Sales at Rs 1,995.00 crore, up 1.48% Y-o-Y

Torrent Pharma Standalone December 2020 Net Sales at Rs 1,616.00 crore, up 9.86% Y-o-Y

Pharma: Ignore the noise as the core allocation is incremental

Focus on creating health infrastructure in the Budget 2021 is clearly an incrementally structural move which should indirectly benefit all the domestic oriented companies

M&M and ACC among top 10 short-term trading ideas for the next 3-4 weeks

All Nifty 50 components are trading above their 200 days SMA, highlighting robust market breadth which gauges the inherent strength of the market, suggest experts.

Torrent Pharma Consolidated September 2020 Net Sales at Rs 2,017.00 crore, up 0.6% Y-o-Y

Buy Torrent Pharma; target of Rs 3200: YES Securities

YES Securities is bullish on Torrent Pharma has recommended buy rating on the stock with a target price of Rs 3200 in its research report dated October 26, 2020.

Reduce Torrent Pharma; target of Rs 2863: Dolat Capital Market

Dolat Capital Market recommended reduce rating on Torrent Pharma with a target price of Rs 2863 in its research report dated October 26, 2020.

Torrent Pharma Standalone September 2020 Net Sales at Rs 1,640.00 crore, up 2.31% Y-o-Y

Torrent Pharma Standalone September 2020 Net Sales at Rs 1,640.00 crore, up 2.31% Y-o-Y

Sell Torrent Pharma; target of Rs 2250: Emkay Global Financial

Emkay Global Financial is bearish on Torrent Pharma has recommended sell rating on the stock with a target price of Rs 2250 in its research report dated July 30, 2020.

Reduce Torrent Pharma; target of Rs 2500: Dolat Capital

Dolat Capital recommended reduce rating on Torrent Pharma with a target price of Rs 2500 in its research report dated July 30, 2020.

Torrent Pharma share price rallies after Q1 profit jumps 48%

Consolidated revenue from operations of the company stood at Rs 2,056 crore for the June quarter.

Torrent Pharma Standalone June 2020 Net Sales at Rs 1,727.00 crore, up 7.74% Y-o-Y

Torrent Pharma Consolidated June 2020 Net Sales at Rs 2,056.00 crore, up 1.68% Y-o-Y

Quant Pick - Torrent Pharma: ICICI Direct

According to ICICI Direct, The Nifty has moved towards the 10000 mark amid a broader market recovery led by underperforming segments like banking.

Sell Torrent Pharma; target of Rs 2038: Emkay Global Financial

Emkay Global Financial is bearish on Torrent Pharma has recommended sell rating on the stock with a target price of Rs 2038 in its research report dated May 26, 2020.

Torrent Pharma Standalone March 2020 Net Sales at Rs 1,491.00 crore, up 9.87% Y-o-Y

Sell Torrent Pharma; target of Rs 2170: Dolat Capital

Dolat Capital is bearish on Torrent Pharma has recommended sell rating on the stock with a target price of Rs 2170 in its research report dated May 26, 2020.

Torrent Pharma Consolidated March 2020 Net Sales at Rs 1,946.00 crore, up 4.85% Y-o-Y

Torrent Pharma Standalone December 2019 Net Sales at Rs 1,471.00 crore, down 0.68% Y-o-Y

Torrent Pharma Standalone December 2019 Net Sales at Rs 1,471.00 crore, down 0.68% Y-o-Y

Torrent Pharma Consolidated December 2019 Net Sales at Rs 1,966.00 crore, down 4.14% Y-o-Y

Torrent Pharma share price falls 5% on weak Q3 nos; Credit Suisse, CLSA retain buy

CLSA maintains outperform call on the stock and raised the target to Rs 2,050. Credit Suisse, too, stuck to outperform call but with the target at Rs 1,700.

Mid & small-caps join the party on D-St; 23 stocks rose 10-40% in BSE 500 index

It looks like Small & midcap stocks have joined the party on D-Street and some of the smart money has started moving in this space especially in the ones which were beaten down, suggest experts.

Market Headstart: Nifty seen opening lower; PSU, telecom stocks eyed

Trends on SGX Nifty indicate a negative opening for the broader index in India, with a 11 points loss at 12,001 levels